Globe Life (GL) delivered mixed results in Q3 FY2026 on revenue of $1.6B versus the $1.6B estimate (+5.5% YoY) and EPS of $4.84. The next Globe Life (GL) earnings date is Feb 3, 2027. Below is the full Globe Life earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
Globe Life (GL) Earnings Analysis — key stats
Next earnings date
Feb 3, 2027
Latest reported quarter
Q3 FY2026
Earnings verdict
Mixed
EPS beat rate
1 of last 8 (quarters above estimate)
Avg next-day move
±3.3% (over the last 8 reports)
Post-earnings direction
Up 3 / Down 5 (of the last 8 reports)
Implied move (next report)
±16.8% (options-derived · into Feb 3, 2027)
Revenue
$1.6B (vs $1.6B est · +2.2% surprise · +5.5% YoY)
EPS
$4.84 (vs $4.90 est · -1.2% surprise · +0.0% YoY)
Share price
$155.99 (-7.4%)
Market cap
$12.0B
Globe Life (GL) Earnings Analysis — beat / miss history
Quarter
Revenue
EPS
EPS surprise
Next-day move
Verdict
Q4 FY2026
$1.6B vs $1.6B est
$4.84 vs $4.90 est
-1.2%
-0.8%
Mixed
Q3 FY2026
$1.6B vs $1.6B est
$3.61 vs $3.67 est
-1.6%
-7.2%
In line
Q2 FY2026
$1.6B vs $1.6B est
$3.43 vs $3.47 est
-1.2%
+2.0%
In line
Q1 FY2026
$1.5B vs $1.5B est
$3.39 vs $3.44 est
-1.5%
+2.3%
In line
Q4 FY2025
$1.5B vs $1.5B est
$4.81 vs $4.60 est
+4.6%
-0.2%
Mixed
Q3 FY2025
$1.5B vs $1.5B est
$3.27 vs $3.25 est
+0.6%
+7.1%
In line
Q2 FY2025
$1.5B vs $1.5B est
$3.07 vs $3.23 est
-5.0%
-5.0%
Mixed
Q1 FY2025
$1.5B vs $1.5B est
$3.14 vs $3.12 est
+0.6%
-2.0%
In line
What you'll find
Next Globe Life (GL) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment Globe Life reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in Globe Life (GL)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is Globe Life's next earnings date?
Globe Life's (GL) next scheduled earnings date is Feb 3, 2027. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Globe Life (GL) beat or miss earnings?
In Q3 FY2026, Globe Life (GL) posted mixed results — revenue of $1.6B versus the $1.6B estimate (+2.2% surprise) and EPS of $4.84 versus $4.90 expected (-1.2% surprise). Magnisto decodes every Globe Life (GL) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
How often does Globe Life beat earnings estimates?
Over its last 8 reported quarters, Globe Life (GL) beat Wall Street EPS estimates 1 time, most recently a mixed result in Q4 FY2026. Magnisto tracks every Globe Life (GL) quarter's revenue and EPS versus consensus and grades each one Beat, Miss, In-line or Mixed at a unified ±2% threshold.
How much does Globe Life stock move after earnings?
Over its last 8 quarterly reports, Globe Life (GL) moved an average of ±3.3% the day after earnings — ranging from -7.2% (Q3 FY2026) to +7.1% (Q3 FY2025). The stock rose after 3 of those 8 reports and fell after 5. Heading into its next report on Feb 3, 2027, options-implied volatility is pricing in a move of roughly ±16.8% (derived). Magnisto tracks the realized post-earnings move for every Globe Life (GL) quarter alongside the beat/miss verdict — past moves don't predict the next one.
What is the forecast for Globe Life (GL) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Globe Life (GL), anchored to the current $155.99 share price, so you can weigh the bull, base and bear cases for Globe Life side by side.
Is Globe Life (GL) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Globe Life fits your own thesis and risk profile. This is research, not investment advice.